Back to search

Article

Development of the novel amylin receptor activators with nanomolar potency by peptide mutagenesis

2024-08-01

Abstract excerpt

Amylin peptide hormone activates amylin receptors in brains and controls blood glucose and appetite. An amylin receptor activator pramlintide was developed for diabetes treatment. Currently, the amylin receptor activator with once-weekly injection has been tested for body weight reduction to treat obesity. Human amylin peptide was reported to form aggregates, while rat amylin has been shown soluble in aqueous solu...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5ec4ef8e-f815-5d40-91c1-ae4998bf725e
DOI
10.1101/2024.07.31.606116
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Development of the novel amylin receptor activators with nanomolar potency by peptide mutagenesisDOI 10.1101/2024.07.31.606116
Select a neighboring publication to make it the new centre.